Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide.
Our expertise in advanced cancer genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. We specialize in high-throughput next-generation sequencing, proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive approaches in cancer.
PGDx was founded in 2010 by Luis Diaz and Victor Velculescu to help bring novel diagnostic approaches to patients with cancer. They are internationally recognized leaders in cancer genomics who have extensive experience in the application of innovative genomic technologies for drug development and clinical practice.
Named a 2019 Top Workplace by The Baltimore Sun
Named a 2018 winner of the Best Place to Work by the Business Intelligence Group
Location: United States, Maryland, Baltimore
Employees: 51-200
Total raised: $202.2M
Founded date: 2010
Investors 6
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | PFM Health... | pfmhealths... |
| - | Johns Hopk... | ventures.j... |
| - | 3B Future ... | 3bfuturehe... |
| - | Catalio Ca... | cataliocap... |
| - | Helsinn In... | helsinninv... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 10.02.2021 | Series C | $103M | - |
| 04.01.2018 | Series B | $75M | - |
| 02.11.2015 | Series A | $21.4M | New Enterp... |
| 02.04.2014 | - | $2.8M | - |
Mentions in press and media 25
| Date | Title | Description | Source |
| 05.08.2021 | Power Moves: Baltimore’s Julius Valentine Maina joins accele... | Power Moves is a column where we chart the comings and goings of talent across the region, and other... | technical.... |
| 15.06.2021 | Personal Genome Diagnostics Enters Collaborative Partnership... | BALTIMORE, MD, June 15, 2021 – Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomi... | 3bfuturehe... |
| 11.06.2021 | Power Moves: Catalyte expands the C-suite with growth in dig... | Power Moves is a column where we chart the comings and goings of talent across the region, and other... | technical.... |
| 12.02.2021 | Daily funding roundup - February 11th, 2021 | Zocdoc raised $150M; Modern Health landed $74M; Human Interest secured $55M; WireWheel picks up $20M... | vator.tv/n... |
| 10.02.2021 | Personal Genome Diagnostics Closes $103 Million Series C | BALTIMORE, Md.--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomic... | citybizlis... |
| 10.02.2021 | Personal Genome Diagnostics raises $103M to take cancer test... | Canton-based Personal Genome Diagnostics (PGDx) raised $103 million in a Series C round, providing n... | technical.... |
| 27.04.2020 | NEA-backed Personal Genome Diagnostics receives FDA clearanc... | Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic prof... | techcrunch... |
| 15.01.2020 | FDA grants priority review for Rubraca; Arpeggio snags... | → Months after the UK’s cost-effectiveness agency NICE had a change of heart on its drug Rubrac... | endpts.com... |
| 10.09.2019 | Another study shows liquid biopsy can detect cancer immunoth... | “Microsatellite instability and high tumor mutation burden are promising pan-tumor biomarkers that a... | medcitynew... |
| 05.10.2018 | Term Sheet — Friday, October 5 | YALE MONEY Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? ... | fortune.co... |
Show more